ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 1290

$579K Total Retail Price of All Prescriptions

Rank: 155 out of 1290

752 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 752 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 752 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 7,045 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 551 433 1 5
SIMVASTATIN 530 438 2 1
FLUTICASONE PROPIONATE 345 257 3 26
OMEPRAZOLE 330 230 4 2
MELOXICAM 280 190 5 31
AMLODIPINE BESYLATE 278 222 6 3
LEVOTHYROXINE SODIUM 233 192 7 4
METFORMIN HCL 231 172 8 10
HYDROCODONE-ACETAMINOPHEN 227 125 S3 9 6
METOPROLOL TARTRATE 212 158 10 7
SERTRALINE HCL 209 127 11 36
ZOLPIDEM TARTRATE 183 133 12 15
HYDROCHLOROTHIAZIDE 149 109 13 20
ATENOLOL 147 115 14 18
ATORVASTATIN CALCIUM 145 109 15 23
CARVEDILOL 136 111 16 12
GABAPENTIN 134 51 17 8
TAMSULOSIN HCL 130 113 18 11
GLYBURIDE 128 112 R 19 87
ADVAIR DISKUS 122 78 20 37
LOSARTAN POTASSIUM 118 105 21 19
GLYBURIDE-METFORMIN HCL 109 92 R 22 147
ALENDRONATE SODIUM 101 88 23 39
WARFARIN SODIUM 97 84 24 22
METOPROLOL SUCCINATE 93 78 25 14
PLAVIX 89 79 26 32
TRAMADOL HCL 88 61 27 25
FUROSEMIDE 87 62 28 9
OXYCODONE-ACETAMINOPHEN 85 37 S2 29 65
CLOPIDOGREL 83 75 30 24
AZITHROMYCIN 79 52 31 61
CLONIDINE HCL 78 56 32 66
DONEPEZIL HCL 76 73 33 13
CRESTOR 76 64 33 17
FAMOTIDINE 72 55 35 128
ISOSORBIDE MONONITRATE ER 69 60 36 58
PREDNISONE 69 57 36 21
SINGULAIR 66 40 38 85
METHOCARBAMOL 62 21 R 39 250
CLOTRIMAZOLE-BETAMETHASONE 61 41 40 153
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 45 41 92
GLIMEPIRIDE 60 36 41 57
ENALAPRIL MALEATE 59 45 43 62
PEN NEEDLE 56 39 44 72
LOVASTATIN 55 44 45 45
PRAVASTATIN SODIUM 53 46 46 42
LOSARTAN-HYDROCHLOROTHIAZIDE 53 37 46 106
CIPROFLOXACIN HCL 53 37 46 46
LANTUS 51 19 49 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.